by Sue Robbins | Jun 7, 2019 | Migraine
Using a migraine disability assessment (MIDAS) score obtained through a patient questionnaire provides additional insight into migraine care, according to a poster presented at ISPOR 2019. The research showed that primary care physicians prescribe preventive therapy...
by Sue Robbins | Jun 6, 2019 | Migraine
Many of the 36 million migraine sufferers in the US turn off their smartphones — any lights and sounds, for that matter — when a headache sets in, so it may come as a surprise that researchers at NYU School of Medicine are touting a de-stressor app they say may help...
by Dr Robbins | Jun 6, 2019 | Headache Drugs, Migraine
Dr Robbins & CGRP Part I We were privileged to have Dr. Lawrence Robbins doing a Facebook Live Chat in our group on May 21, 2019. Dr Robbins talked about the CGRP Medications one year after the first medication was FDA approved, and answered questions about how...
by Sue Robbins | Jun 5, 2019 | Headache Drugs
The U.S. Food and Drug Administration on Tuesday gave the nod to Emgality, an injected medication that’s the first to cut the frequency of cluster headaches. 6-5-19. Read more here.
by Sue Robbins | Jun 4, 2019 | Migraine
Between 30 and 50% of migraineurs will sometimes experience dizziness, a sense of spinning, or feeling like their balance is off in the midst of their headaches. This is now termed vestibular migraine, but is also called migraine associated vertigo. Sometimes...
